![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 2, 1398-1404, January 14, 2000
andFrom the Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0524
| |
ABSTRACT |
|---|
|
|
|---|
Using a Drosophila transgenic system
we investigated the ability of GAGA factor, a putative anti-repressor,
to modulate transcription-related events in the absence or presence of
a bona fide activator, the Adf-1 transcription factor. In
contrast to previous in vitro and in vivo data
linking the binding of GAGA factor to the acquisition of DNase
hypersensitivity at heat shock promoters, we observed that inserting
multiple GAGA binding motifs adjacent to a minimal alcohol
dehydrogenase (Adh) promoter led to strongly elevated embryonic transcription without creation of a promoter-associated DNase-hypersensitive (DH) site. Establishment of DNase hypersensitivity required the presence of both GAGA and Adf-1 binding sites and was
accompanied by a further, synergistic increase in transcription. Because Adf-1 is capable neither of establishing a DH site nor of
promoting efficient transcription by itself in embryos, it is likely
that DH site formation depends on a GAGA factor-mediated binding of
Adf-1 to chromatin, perhaps facilitated by a locally remodeled
downstream promoter region. More generally we suggest that GAGA
factor-binding sequences may operate in a promoter-specific context,
with transcriptional activation, polymerase pausing, and/or DH site
formation critically dependent on the nature of the sequences (and
their binding partners) linked in cis.
Control of eukaryotic transcription is a complex, tightly
regulated process requiring the action of many distinct proteins, including chromatin-interacting/modifying proteins, transcriptional activators, and general transcription factors
(GTFs)1 (for review see Refs.
1-3). In addition to recent progress in determining the role of
chromatin-interacting proteins, unraveling the mechanisms by which
sequence-specific, DNA-binding activators promote transcription has
traditionally occupied a good deal of effort in the field. The
consensus emerging from studies on many activators is that a
significant activity of these proteins is to recruit components of the
general transcription machinery and/or chromatin-interacting factors to
promoters through direct protein-protein interactions (4).
The Drosophila GAGA factor is unusual in that its activity
in transcription appears to be neither that of a purely
sequence-specific transactivator nor that of an
ATP-dependent chromatin-interacting factor. GAGA protein
was first identified as a transcription factor that bound a repetitive
GA element upstream of the engrailed (5) and
Ultrabithorax (6) promoters. So-called GAGA elements have subsequently been identified in numerous promoters, including those
controlling housekeeping, developmentally regulated, and inducible
genes (7). GA repeats appear to be important in the acquisition of
constitutive DNase I-hypersensitive (DH) sites found at the
transcriptionally inactive but inducible hsp26 (8) and
hsp70 (9) promoters in vivo. Moreover, in concert
with the ATP-dependent nucleosome remodeling factor (NURF),
GAGA factor aids in the local remodeling of GAGA element-containing
chromatin templates in vitro (10-12), including the
establishment of DH sites at an hsp70 promoter (10). Other
in vitro studies have revealed that although GAGA factor
stimulates transcription of repressed promoters, it does not activate
transcription above basal (i.e. nonrepressed) levels
(12-14). Null mutations of the Trithorax-like (Trl) gene, which encodes GAGA factor, result in larval
lethality (15), whereas less severe alleles show enhancement of
position effect variegation as well as deficiencies in chromosome
condensation, segregation, and nuclear cleavage (15, 16). Taken
together, the data suggest a role for GAGA factor in establishing or
maintaining particular chromatin structures. A model has emerged where,
when located in the vicinity of a promoter, GAGA factor facilitates promoter activation not by actively recruiting GTFs but rather by
functioning as an anti-repressor molecule. GAGA factor binding is
proposed to promote local displacement or disruption of nucleosomes in
creating a DNase I-hypersensitive site, thereby allowing bona fide activators and/or the general transcription machinery to gain
access to DNA at promoter regions (Refs. 10 and 17; for review see Ref.
18).
Because much of the aforementioned work on GAGA factor has employed
complex, multi-factor binding promoters or in vitro
conditions, we sought to clarify the activity of GAGA factor in
vivo in the context of a defined promoter at the level of both
transcription and chromatin perturbation. In addition, it was of
interest to ask the same question of a bona fide activator
for direct comparison. For this latter purpose we chose Adf-1, first
identified as a regulator of the alcohol dehydrogenase (Adh)
distal promoter (19) and subsequently shown to bind the
antennapedia P1 and dopa decarboxylase promoters
(20) and the ftz-proximal enhancer (21). In our experiments,
therefore, we have analyzed Drosophila carrying transgenes consisting of GAGA factor or Adf-1-binding elements, either alone or in
combination, upstream of a minimal Adh distal promoter. Unexpectedly, we find that GAGA factor alone is able to stimulate embryonic transcription markedly in vivo, whereas Adf-1 is a
relatively poor activator when operating unaided in these cells. As
might be anticipated, the highest levels of transcription are achieved through a synergistic contribution of these two independent activities. A second, unforeseen result is that a promoter-proximal DH site is
established only in the presence of both activities rather than via the
action of GAGA factor alone. Therefore, in the context of the
Adh distal promoter, GAGA factor and Adf-1 synergize both at
the level of activating transcription and of modulating chromatin structure.
Construction of the P Element Constructs and Transgenic
Lines--
All recombinant DNA procedures were performed using
standard techniques (22); full details can be provided upon request. In
outline, a minimal derivative of the Drosophila distal
Adh promoter ( Chromatin Analyses--
Nuclei were isolated from 2.5 g of
frozen embryos as described previously (26). A minimum of two
independently transformed lines was tested in each assay. For DNase I
treatment, nuclei were resuspended in 1 ml of DNase I digestion buffer
(60 mM KCl, 15 mM NaCl, 15 mM
Tris-HCl, pH 7.4, 3 mM MgCl2, 0.5 mM dithiothreitol, 0.25 M sucrose) and
dispensed as 250-µl aliquots. Increasing amounts of DNase I
(Worthington) were added, samples were incubated on ice for 3 min, and
reactions were stopped with 5 µl of 0.4 M EDTA, pH 8.0. 8-10 µg of purified genomic DNA was digested with either SstI and EcoO109I or BamHI (as
indicated in Fig. 3), subjected to gel electrophoresis in a 1.2%
agarose gel, transferred to Gene Screen Plus membrane (Amersham
Pharmacia Biotech), and probed with the appropriate
32P-labeled fragment (see figure legend). For the
micrococcal nuclease (MNase) digestions, nuclei were resuspended in 1 ml of MNase digestion buffer (60 mM KCl, 15 mM
NaCl, 15 mM Tris-HCl, pH 7.4, 2 mM
CaCl2, 0.5 mM dithiothreitol, 0.25 M sucrose) and dispensed as 250-µl aliquots. Increasing
amounts of MNase (Worthington) were added, tubes were incubated at
25 °C for 5 min, and reactions were stopped with 5 µl of 0.4 M EDTA, pH 8.0. 10 µg of isolated genomic DNA was
subjected to Southern blot analysis as above. For the restriction enzyme analyses, nuclei were resuspended in 750 µl of the appropriate enzyme digestion buffer containing the following protease inhibitors, phenylmethylsulfonyl fluoride (0.5 mM), leupeptin (5 mg/ml), and aprotinin (0.1 unit/ml) and dispensed as 250-µl aliquots.
Various concentrations of either PstI or BamHI
were added, as indicated in Fig. 5, tubes were incubated at 37 °C
for 45 min, and reactions were stopped with 5 µl of 0.4 M
EDTA, pH 8.0. 8-10 µg of isolated genomic DNA was digested with
SstI and EcoO109I and subjected to Southern blot
analysis as above.
Transcription Analyses--
To prepare embryonic extracts,
approximately 25-50 mg of 0-12-h embryos were dechorionated by
incubation in 50% bleach for 3 min, washed thoroughly, placed into a
microcentrifuge tube containing 100 µl of lysis buffer (1% Triton
X-100, 25 mM glycylglycine, 15 mM
MgSO4, 4 mM EGTA, 1 mM
dithiothreitol, pH 7.8), and homogenized using a Kontes pestle. For
adult extracts, 10 anesthetized flies were homogenized in 100 µl of
lysis buffer. Both extracts were cleared by 5 min of centrifugation at
4 °C. 10-20 µl of extract was analyzed for luciferase activity
using the luciferase reporter assay system (Promega). Luciferase
activity for each sample was normalized for protein concentration and
adjusted for background luminescence by subtracting the signal obtained
from samples derived from the nontransgenic parental line.
Strategy for Investigating the Role of GAGA Factor in Gene
Activation in Vivo--
To systematically investigate the in
vivo activity of GAGA repeats and presumably GAGA factor binding,
our approach was to add an extensive GAGA element upstream of either a
minimal promoter or a promoter containing the binding site for an
activator, linked to a reporter gene. We assayed homozygous transgenic
lines generated by P element-mediated transformation (25) carrying one
of four possible constructs for their effects on luciferase reporter
gene activity and perturbations in chromatin structure.
GAGA Factor and Adf-1 Synergize to Activate
Transcription--
Both GAGA factor and Adf-1 are known to be players
in the transcriptional activation of specific RNA polymerase
II-regulated genes in Drosophila. Adf-1 is believed to
recruit specific GTFs to the promoter (27). GAGA repeats have been
shown to be important for transcription in vivo of
hsp26 (28), hsp70 (29), and
Ultrabithorax (30). For our study we utilized the
hsp26-proximal GAGA element. This element is one of the
longest GAGA repeats characterized, with 35 nucleotides protected in
footprinting assays, most likely reflecting the binding of multiple
GAGA proteins along its length (31, 32). We created the following
transgenic lines (Fig. 1):
control, consisting of a TATA box-containing promoter
derived from the distal transcription unit of Adh;
Adf-1, containing the binding site for this transactivator
in its natural position at the Adh promoter;
GAGA, containing the hsp26-proximal GAGA element 5' of the promoter; and GAGA+Adf-1, containing both
elements. Inspection of the Adh promoter used shows there
are additional short GAGA elements present, located at
In whole cell extracts of 0-12-h embryos from the various transgenic
lines, luciferase transcription is increased slightly (3-fold) in the
Adf-1 and significantly (15-fold) in the GAGA lines, relative to those carrying the control transgene
(Fig. 2 and Table
I). Combining these two elements in a
single construct (GAGA+Adf-1) has a synergistic effect, with
an average 29-fold activation. The relative patterns of transcription
activation in adults are altered somewhat from those seen in embryos,
with an even greater degree of synergy observed in the
GAGA+Adf-1 lines (Table I). It is important to note,
however, that the absolute levels of transcription are substantially
lower in adults, possibly because of low concentrations of GAGA factor
resulting from a significantly decreased amount of its mRNA in
adults compared with embryos (35). In addition, the several GAGA
mRNA species present in adults produce a variety of protein
isoforms (35, 36) that may have distinct functions. Furthermore, there
could be differential adult stage- or tissue-specific variations in Adf-1 and GAGA factor expression patterns relative to their ubiquitous expression in embryos (35, 37). Overall, these results indicate that
GAGA factor acting alone at a minimal promoter can lead to significantly elevated levels of transcription in vivo and,
additionally, that GAGA factor and Adf-1 synergize in transcription
activation.
DNase I-hypersensitive Site Generation Requires the Cooperative
Action of Both GAGA Factor and Adf-1--
Traditionally, DH sites have
been thought to demarcate regions of chromatin that are either
nucleosome-free or markedly disrupted (38). In vivo and
in vitro analyses from several laboratories have revealed
that GAGA sequences are one important component in the formation of
constitutive DH sites at both the hsp26 and hsp70
promoters. However, multiple sequence elements in these promoters can
quantitatively contribute to DH site generation and the loading of the
transcriptional apparatus (8, 17, 18). We tested for the presence of DH
sites in 0-16-h embryos of several transgenic lines carrying each of
the constructs outlined in Fig. 1. Unexpectedly, introduction of the
extensive hsp26-proximal GAGA element does not lead to the
creation of a DH site in the vicinity of the minimal Adh
promoter (Fig. 3A,
lanes 7-9). Similarly, no DH site was observed in the
Adf-1 lines (Fig. 3A, lanes 4-6). Only those lines carrying the GAGA+Adf-1 transgene exhibit a
DH site at the promoter (Fig. 3A, lanes 10-12;
note its very close correspondence with the location of the
AvaII site at In Vivo Effects of GAGA Factor on Nucleosome
Integrity--
Because the GAGA transgenes exhibited a
strong stimulation of transcription but no detectable DH site
formation, we sought to determine what kind of more subtle changes, if
any, in chromatin structure might be associated with the presence of
GAGA factor adjacent to the Adh promoter. Brief treatment of
chromatin with MNase followed by gel analysis of purified DNA reveals a
pattern of DNA fragments increasing in size by approximately 200-base pair increments derived from digestion within linker DNA at mono-, di-,
tri-nucleosomal, etc., intervals. MNase analysis of the
hsp70 (10), hsp26 (11), and ftz (12)
promoters reconstituted into chromatin in vitro showed that
addition of GAGA factor, in the presence of both embryonic nuclear
extract and ATP, led to a localized disruption of the nucleosomal array
at the GAGA sequences. Because both co-factors were essential, it was
suggested that the observed remodeling depended critically on the
presence of NURF in the extract. To assess the ability of GAGA factor
to locally remodel nucleosomal arrays in vivo on a simple
model promoter, we conducted MNase digestion analysis on embryonic
nuclei derived from each of the transgenic lines.
Short probes located immediately adjacent to (and on either side of)
the insertion site can reveal the local effects of individual inserts
across the various lines. Using a sequence probe derived from directly
downstream of the insertion (encompassing both the Adh
promoter and the immediately 5' portion of the luciferase gene), those
lines that contain the GAGA element reveal an altered, much less
distinct, local nucleosomal pattern relative to the control
and Adf-1 lines (Fig.
4A, compare lanes
5-8 with lanes 1-4; densitometric tracing of
lanes 2, 4, 6, and 8 is
shown in Fig. 4D). Probing immediately upstream of the
insertion site reveals rather little in the way of obvious perturbation
in comparing any of the lines (Fig. 4B; see Fig.
4E for a densitometric trace). Moreover, when the same blot
is probed with a DNA sequence derived from the endogenous
hsp26 gene (Fig. 4, C and F), a
regular and distinct nucleosomal ladder is present in all four of the
transgenic lines, showing that the perturbations observed in the
GAGA and GAGA+Adf-1 lines in Fig. 4A
were genuine and not an experimental artifact. Because the same blot
was used to produce the clearly differing data of Fig. 4 (compare
A with B), it appears that the perturbations seen
are extremely localized and directed downstream of the insertion site
over the promoter and/or transcribed region. Lastly, because these
downstream perturbations appear to be unequivocally associated with the
presence of the GAGA element (none seen in the control or
Adf-1 lines), they exist independently of the presence of
both the Adf-1-binding site in DNA and the DH site in chromatin.
In a further attempt to measure the extent and location of GAGA
factor-associated chromatin structure perturbation, we investigated restriction enzyme accessibility in and around the promoter region of
the transgenes. A PstI site lies directly 3' of the GAGA
element, whereas a BamHI site is approximately 60 base pairs
upstream of its 5' end (Fig. 1). In embryonic nuclei, PstI
accessibility within the transgene increases moderately in the
GAGA lines and is highest in the GAGA+Adf-1 lines
(Fig. 5A). In contrast, the
level of BamHI (Fig. 5B) accessibility is, if
anything, moderately reduced in the GAGA element-containing lines.
These results signify a fairly localized and modest downstream
perturbation effect and are in general agreement with the MNase data.
In addition, we monitored the ability of T7 RNA polymerase (T7RP) to
transcribe from its promoter located around 30 bp upstream of the
insertion site (Fig. 1). T7RP is a single polypeptide enzyme that has
been used previously as a probe for monitoring DNA accessibility in
chromatin (for examples, see Refs. 40 and 41). The addition of T7RP to
nuclei isolated from a GAGA+Adf-1 line produced no increase
in RNA transcripts relative to the amount generated in nuclei from the
control line (data not shown), confirming that the chromatin
perturbation in the GAGA+Adf-1 line is localized to the
Adh promoter and/or the luciferase transcribed region and
does not extend into a closely adjacent upstream region.
Role of GAGA Factor in Trans-activation versus Chromatin
Perturbation--
GAGA factor has been classified as a chromatin
anti-repressing factor rather than a conventional activator (for review
see Ref. 18). Carefully controlled in vitro experiments
showed that GAGA factor had no overt transcription activating ability
on naked DNA templates (13, 14) but could relieve the repression of basal transcription at a linked promoter assembled into chromatin when
the remodeling factor NURF was present (12). The observed stimulation
of transcription by GAGA factor in crude extracts or transient assays
(35, 36, 42) might then reflect its ability to partake in the
suppression or destabilization of the many nonspecific DNA-protein
interactions that are likely to occur on DNA templates in such assays.
With GAGA factor characterized purely as an anti-repressor, therefore,
we were intrigued to find that the placement of high affinity
GAGA-binding sites adjacent to a minimal Adh TATA promoter was sufficient for robust stimulation of transcription in an in vivo chromatin context (Fig. 2 and Table I). Two alternative, although not mutually exclusive, explanations could account for this
activity. First, localized chromatin destabilization or nucleosome sliding in the vicinity of the TATA promoter, modulated in part by GAGA
factor binding to its adjacent recognition site (presumably aided by
the remodeling activity of the NURF complex Refs. 10 and 43), might
allow access of the general transcription machinery to the promoter via
binding of TATA-binding protein and the GTFs. In other words the
stimulation of in vivo transcription purely by GAGA factor,
as seen here, would be analogous to its in vitro ability to
establish basal transcription. Considered in this light, the presence
of promoter-proximal GAGA elements might be a way of achieving a
measure of constitutive transcription in vivo against the
normally repressive chromatin background. The data presented in Figs.
4A and 5A show a perturbation of the promoter
region and/or downstream nucleosomal array in the presence of the GAGA element, but because the transcription machinery is clearly also present and functional in these cases, it is not possible to
unambiguously ascribe the cause of this downstream chromatin disruption
to GAGA factor binding alone (though neither can it be ruled out on
this evidence). The reduction in accessibility of the upstream
BamHI site when GAGA elements are present (Fig.
5B) would be consistent with a GAGA factor-induced sliding
of a nucleosome into this location, an effect of GAGA factor binding to
an in vitro reconstituted chromatin template that was noted
by others (11). However, when we attempted to map nucleosomal positions
in the promoter region by a relatively low resolution indirect end
labeling analysis of MNase digested samples, we found no clear
difference in the cleavage patterns of the control lines
compared with the GAGA lines (data not shown), suggesting
the effects of GAGA factor on transcription were not related to a major
repositioning of the nucleosomal array at the promoter. Only in the
GAGA+Adf-1 line did we observe an obvious change in the
promoter-proximal MNase cleavage pattern, consistent with the unique
establishment of a DH site in these lines (shown in Fig. 3). A second
interpretation of the GAGA activity seen here is that GAGA factor acts
as a conventional activator that (directly or indirectly) leads to
active recruitment of the general transcription machinery. GAGA factor
does have a glutamine-rich region, a domain found in one class of
activator proteins (44), and whereas this domain can clearly lead to
self-aggregation of GAGA factor (45, 46), the only transcription factor
so far known to interact with it is heat shock factor (47). More interestingly perhaps, this GAGA domain has recently been found to
promote distortion of downstream DNA (45), a perturbation that could
facilitate the binding of TATA-binding protein and/or GTFs in accord
with the general mechanism envisioned by the first model.
It is particularly important to consider our in vivo
transcription data in the light of extensive transcription studies
performed on GAGA element-containing Drosophila heat shock
promoters. A distinctive property of these promoters is that, in the
absence of an activated transcription factor (i.e. the heat
shock factor protein), RNA polymerase II is present on the promoter in
a transcriptionally initiated, but "paused" condition, a feature
that is critically influenced by the presence of upstream GAGA elements
(9, 17, 29). To a limited extent then, our data are in agreement,
inasmuch as we observe GAGA-dependent loading of polymerase
(measured by strongly increased transcription in the GAGA
lines) in the absence of an overt transactivator known to function via
recruitment. However, a crucial difference is that although the minimal
Adh promoter used here clearly allows passage of RNA
polymerase II into productive elongation under the influence of
adjacent GAGA elements, the initiated polymerase at heat shock
promoters falls into arrest immediately downstream and can only be
released into elongation upon binding of the activated heat shock
factor protein to sites upstream from the promoter. Recent in
vitro reconstitution of a paused polymerase on the
Drosophila hsp70 gene strongly suggests that an important
element of pausing is inherent to the sequence contained within the
heat shock promoter itself (48, 49). The absence of such sequence
elements (or, conversely, presence of different elements) in the
minimal Adh promoter, provides a plausible (and testable)
explanation for why productive elongation is able to take place in the
presence of GAGA factor alone in the experiments reported here. We are
currently conducting promoter swap experiments to assess this potential
promoter-specific contribution to the in vivo activity of
GAGA factor.
Multiple GAGA Elements Are Insufficient for DH Site
Establishment--
In considering previous studies on the structural
consequences of GAGA factor binding conducted on in vitro
reconstituted chromatin templates (particularly at heat shock
promoters), the absence of a DH site in vivo at the promoter
of the transcriptionally active transgenic GAGA lines (Fig.
3, lanes 8 and 9) is a further unexpected result.
Its absence is unlikely to be related to the demonstrated requirement
for three or more independent GAGA elements to generate a DH site
in vitro (10). In our constructs, there are two short GAGA
sites in the minimal Adh promoter itself that are known to
be binding targets both in vitro (33) and in vivo (50), as well as the 42-bp GAGA element derived from hsp26, a sequence that appears capable of binding multiple copies of the GAGA
factor (33). Although GAGA elements contribute to the full
manifestation of DNase I hypersensitivity at heat shock promoters, it
appears that other promoter-proximal sequence elements and nonhistone
trans-acting factors play some role in its establishment (see Refs. 8-11, 43, and 51). Again we suggest that one or more such
sequence elements are absent from the minimal Adh promoter studied. Furthermore, it is important to reiterate that our data reflect the results of a true in vivo situation, where the
levels of GAGA factor are natural and not achieved by in
vitro manipulation or use of a purified or recombinant protein.
Our results show that gene "activation," mediated here by GAGA
factor, is not necessarily accompanied by DH site formation at the
promoter either as a necessary prerequisite for or consequence of
transcription. In fact, we feel strongly that the differential
manifestations of GAGA activity seen here, in comparison with studies
on heat shock promoters in particular, are rather convincing indicators
of a promoter-specific context to the function of GAGA factor, with the
nature of cis-linked sequences playing a critical role in
the process.
The promoter-proximal DH site seen in the GAGA+Adf-1 lines
(Fig. 3) may reflect a DNA structural perturbation created by the efficient binding of Adf-1 in the presence of GAGA factor. Gao and
Benyajati (33) have noted that Adf-1 binding to DNA in vitro creates a strong structural perturbation 3' of the Adf-1-binding site,
but neither the binding of Adf-1 nor the DNA distortion are influenced
by adjacent GAGA factor binding; apparently there is no direct
interaction between the proteins. We propose that in the context of the
multiple GAGA element-containing chromatin template studied here, both
transcriptional synergy and DH site establishment are readily explained
by cooperative binding of Adf-1 and GAGA factor to chromatin. This
occurs independently of protein-protein contacts between the two
species (33) but may be facilitated by altered histone-DNA interactions
or downstream DNA distortions mediated either by the GAGA factor itself
or in conjunction with NURF (Fig. 4). A similar cooperative
mechanism dependent on structural perturbation has been advanced
to account for high levels of activation in model yeast
extrachromosomal plasmid templates (52).
GAGA Factor Activities in Context--
These observations
highlight the point that gene activation may be achieved by a variety
of complementary, often synergistic, mechanisms, and it will usually be
the case that a hierarchy of different activities are assembled at
individual promoters to allow fine tuning of the level of gene
expression. It is certainly intriguing to note that GAGA elements are
found linked to a number of different types of promoter in
Drosophila, some inducible, some developmentally regulated,
and some constitutively active (7, 18). Moreover, GAGA factor plays
other roles in chromosomal metabolism that are not obviously related to
transcription (53, 54). Our results, together with those of others,
show that the transcriptional effects of linking GAGA elements to a
promoter and the corresponding influence on the local structure of
chromatin may depend rather critically on the promoter context from
which the data are obtained. The biochemical activities and potential interacting partners of the various GAGA factor isoforms are at present
either ill-defined or undefined. Others have described transcription
factors, e.g. GAL4-VP16 or NF-
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
41 to +20) driving a luciferase reporter
gene was isolated from p-41ADHLUC (kind gift from A. Brasier) and
subcloned into the EcoRV site of pBluescriptSKII(
)
(Stratagene) to generate pSK:L. The su(Hw)-binding element of the gyspy
retrotransposon was isolated by SalI digestion of pGBaBx
(23) and inserted at the XhoI site of pSK:L to generate
pSK:LS. A bacterial lacZ gene flanked by promoter and
terminator sequences for T7 RNA polymerase was cloned into the
BamHI site of pSK:LS, in a divergent orientation relative to
the Adh-luciferase transcription unit, to generate pSK:ZLS.
For the GAGA construct, single-stranded synthetic
oligonucleotides comprising the proximal GAGA element of
Drosophila hsp26 (
125 to
80) (along with appropriate
flanking restriction sites) were annealed and inserted between the
PstI and SmaI sites of pSK:ZLS, i.e.
in the region between the T7 RNA polymerase and Adh
promoters, to generate pSK:ZGLS. For the Adf-1 and
GAGA+Adf-1 constructs, we performed polymerase chain
reaction using p-89ADHLUC (kind gift from A. Brasier) to generate an
approximately 180-bp product spanning regions
89 to +20 of the
Adh distal promoter fused to the luciferase gene and used
this product to replace the
41Adh promoter derivative in
both pSK:ZLS and pSK:ZGLS to generate pSK:ZALS and pSK:ZGALS. The
SpeI-KpnI fragment from each of pSK:ZLS,
pSK:ZGLS, pSK:ZALS, and pSK:ZGALS, which included the lacZ,
luciferase, and su(Hw) regions, was subcloned into pC4:S linearized
with KpnI and SpeI. pC4:S is a derivative of the
pCaSpeR4 P element vector (24) containing a su(Hw)-binding element at
its XhoI site; thus in the final constructs, both
transcription units were now flanked by insulator sequences. Multiple
homozygous transgenic lines carrying single site insertions of the
transgenes were generated by the standard P element-mediated
transformation protocol (25).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
41 to
37 and
at +8 to +11 (33). Reiterated su(Hw)-binding sites derived from the
gypsy retrotransposon flank the transgene. These "insulator"
elements were anticipated to eliminate potential position effects in
the multiple lines analyzed (34).

View larger version (19K):
[in a new window]
Fig. 1.
Schematic of the transgenes used to study
GAGA factor activity. A, sequences common to each of
the transgenes are shown, with the promoter region expanded for
clarity. In the control construct a luciferase reporter gene
is driven by a minimal RNA polymerase II promoter (shaded)
derived from the Drosophila Adh distal promoter (
41 to
+20); the position of the TATA element within the promoter is also
depicted. Approximately 20 bases upstream of the Adh
promoter the bacteriophage T7RP promoter (
23 to +26) was cloned in
divergent orientation. This was included in the constructs to allow for
additional measurements of DNA accessibility in chromatin. All
constructs are flanked by su(Hw)-binding elements derived from the
gypsy retrotransposon. B, various insertions made between
the two promoters. The Adf-1 construct contains the binding
element for Adf-1 in its natural context upstream of the Adh
promoter (
89 to
42). The GAGA construct contains the
proximal GAGA element (
125 to
80) of the Drosophila
hsp26 regulatory region. The GAGA+Adf-1 construct
consists of both elements upstream of the promoter.
, pertinent
restriction sites; B, BamHI; P,
PstI; A, AvaII. The angled
arrows above each construct indicate the approximate positions of
transcription start sites, whereas open arrows below each
construct indicate the additional GAGA sites present in the
Adh promoter (see "Discussion").

View larger version (23K):
[in a new window]
Fig. 2.
GAGA factor and Adf-1 work synergistically to
activate embryonic transcription in vivo. Whole
cell extracts derived from 0-12-h transgenic embryos were analyzed for
luciferase activity. Bars represent activity from a minimum
of three independent experiments for each indicated transgenic line.
RLU, relative light units.
Summary of transgene-specific transcriptional activity
27 bp). As a control for adequate DNase I
treatment, prominent DH sites can be easily detected upstream of the
endogenous hsp26 promoter (39) in all transgenic lines
tested using the identical DNase I-treated samples (Fig. 3B,
DH sites denoted by asterisks). This result indicates that,
at the transgene, GAGA factor works in concert with Adf-1 to generate
DNase I hypersensitivity. Neither GAGA factor nor Adf-1 independently
has the ability to induce a DH site in the context of the minimal
Adh promoter tested here.

View larger version (51K):
[in a new window]
Fig. 3.
A promoter-proximal DNase I-hypersensitive
site is present only in the GAGA+Adf-1 line. DH
sites (indicated by asterisks) were mapped by indirect end
labeling in embryos of the following transgenic lines:
control (lane 1), Adf-1 (lane
4), GAGA (lane 3), and GAGA+Adf-1
(lane 11). A, purified DNA was digested to
completion with SstI and EcoO109I and analyzed by
Southern blot with a probe consisting of the 593-bp
EcoRI-EcoO109I fragment of luciferase as
indicated. Amount of DNase per sample: 0 units (lanes 3,
4, 7, and 10), 30 units (lanes
2, 5, 8, and 11), or 60 units
(lanes 1, 6, 9, and 12).
Lanes 13 and 14 contain restriction-digested
control plasmid DNA as location markers (M);
BamHI and AvaII sites adjacent to the promoter
are indicated by arrows at the side. B, DNA
samples identical to those in A were digested to completion
with BamHI and analyzed by Southern blot with a probe
consisting of an ~2-kilobase BamHI-EcoRI
fragment derived from the endogenous hsp26 gene. Amount of
DNase per sample: 0 units (lanes 1, 5,
9, and 13), 10 units (lanes 2,
6, 10, and 14), 30 units (lanes
3, 7, 11, and 15), and 60 units
(lanes 4, 8, 12, and
16).

View larger version (56K):
[in a new window]
Fig. 4.
Effect of the hsp26-proximal
GAGA element on the local nucleosomal array. Following MNase
treatment of embryonic nuclei derived from various transgenic lines (as
in Fig. 3), genomic DNA was isolated and analyzed by Southern blot. A
single filter was probed with three different DNA fragments: a 220-bp
fragment encompassing the Adh promoter and 5' region of the
luciferase gene (A), a 140-bp fragment from the immediately
upstream region (B), and a fragment derived from the coding
region of the endogenous hsp26 gene (as in Fig.
3B) (C). Units of MNase: 7.5 units (lanes
1, 3, 5, and 7) and 15 units
(lanes 2, 4, 6, and 8).
D-F, a densitometric trace was made of the nucleosomal
array for each of the various transgenic lines shown in
A-C, respectively. Lanes 2, 4,
6, and 8 from each autoradiogram were analyzed
using NIH Image software. A schematic of the control transgene with
probe size and location indicated by the heavy black bars is
shown below; the location of the various insertions is indicated by the
open triangle.

View larger version (49K):
[in a new window]
Fig. 5.
Accessibility of chromatin to restriction
enzymes in the transgenic lines. Isolated embryonic nuclei were
incubated with increasing amounts of the indicated restriction enzyme.
Purified DNA was subjected to indirect end labeling analysis as
described in Fig. 3A; the location of the relevant
restriction sites is depicted in Fig. 1. A, PstI
digestion: 0 units (lanes 1, 4, and
7), 150 units (lanes 2, 5, and
8), and 350 units (lanes 3, 6, and
9). B, BamHI digestion: 0 units
(lanes 1, 4, and 7), 150 units
(lanes 2, 5, and 8), and 350 units
(lanes 3, 6, and 9). The percentage
site accessibility was calculated as the density ratio of the digested
fragment relative to the sum of the parent band (P) plus the
digested fragment using a Molecular Dynamics PhosphorImager and
ImageQuant software. Each individual line was analyzed a minimum of
three times, and the ratio given (indicated below the bar
under the appropriate samples) represents the average site
accessibility across a minimum of two independent lines for each
transgenic construct. (The control samples in lanes
1-3 of A are relatively overloaded, but the density
ratio shown is directly comparable with those of the other samples in
A.)
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
B, that are most likely
able to combine both an anti-repressing and a transactivation function
in a single entity (55, 56). It may be that GAGA factor, given a
particular promoter or other cis-linked sequence context,
can display one or more such capabilities depending on the
combinatorial opportunities presented by that promoter sequence.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Michelle Barton, Alison Crowe, and Jun Ma for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by NIEHS, National Institutes of Health Grant P30-ES06096.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of an Albert J. Ryan Fellowship. Partially supported by
NCI, National Institutes of Health Grant T32-CA59268. Present address:
Cell Biology and Metabolism Branch, NICHD, NIH, Bethesda, MD 20892.
§ To whom correspondence should be addressed: Dept. of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, 231 Bethesda Ave., Cincinnati, OH 45267-0524. Tel.: 513-558-5532; Fax: 513-558-8474; E-mail: cartwril@ucmail.uc.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GTF, general transcription factor; DH, DNase I-hypersensitive; NURF, nucleosome remodeling factor; Adh, alcohol dehydrogenase; MNase, micrococcal nuclease; T7RP, T7 RNA polymerase; bp, base pair(s).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Cairns, B. R. (1998) Trends Biochem. Sci. 265, 20-25 |
| 2. | Kadonaga, J. T. (1998) Cell 92, 307-313[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Tsukiyama, T., and Wu, C. (1997) Curr. Opin. Genet. Dev. 7, 182-191[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Ptashne, M., and Gann, A. (1997) Nature 386, 569-577[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Soeller, W. C.,
Poole, S. J.,
and Kornberg, T. B.
(1988)
Genes Dev.
2,
68-81 |
| 6. | Biggin, M. D., and Tjian, R. (1988) Cell 53, 699-711[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Granok, H., Liebovitch, B. A., Shaffer, C. D., and Elgin, S. C. R. (1995) Curr. Biol. 5, 238-241[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Lu, Q., Wallrath, L. L., Allan, B. D, Glaser, R. L., Lis, J. T., and Elgin, S. C. R. (1992) J. Mol. Biol. 225, 985-998[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Weber, J. A., Taxman, D. J., Lu, Q., and Gilmour, D. S. (1997) Mol. Cell. Biol. 17, 3799-3808[Abstract] |
| 10. | Tsukiyama, T., Becker, P. B., and Wu, C. (1994) Nature 367, 525-531[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Wall, G., Varga-Weisz, P. D., Sandaltzopoulos, R., and Becker, P. B. (1995) EMBO J. 14, 1727-1736[Medline] [Order article via Infotrieve] |
| 12. |
Okada, M.,
and Hirose, S.
(1998)
Mol. Cell. Biol.
18,
2455-2461 |
| 13. |
Kerrigan, L. A.,
Croston, G. E.,
Lira, L. M.,
and Kadonaga, J. T.
(1991)
J. Biol. Chem.
266,
574-582 |
| 14. |
Croston, G. E.,
Kerrigan, L. A.,
Lira, L. M.,
Marshk, D. R.,
and Kadonaga, J. T.
(1991)
Science
251,
643-649 |
| 15. | Farkas, G., Gausz, J., Galloni, M., Reuter, G., Hyurkovics, H., and Karch, F. (1994) Nature 371, 806-808[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Bhat, K. M., Farkas, G., Karch, F., Hyurkovics, H., Gausz, J., and Schedl, P. (1996) Development 122, 1113-1124[Abstract] |
| 17. |
Shopland, L. S.,
Hirayoshi, K.,
Fernandes, M.,
and Lis, J. T.
(1995)
Genes Dev.
9,
2756-2769 |
| 18. |
Wilkins, R. C.,
and Lis, J. T.
(1997)
Nucleic Acids Res.
25,
3963-3968 |
| 19. | Heberlein, U., England, B. P., and Tjian, R. (1985) Cell 41, 965-977[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
England, B. P.,
Heberlein, U.,
and Tjian, R.
(1990)
J. Biol. Chem.
265,
5086-5094 |
| 21. |
Han, W., Yu, Y.,
Su, K.,
Kohanski, R. A.,
and Pick, L.
(1998)
Mol. Cell. Biol.
18,
3384-3394 |
| 22. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 23. |
Peifer, M.,
and Bender, B.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
9650-9654 |
| 24. | Thummel, C. S., and Pirrotta, P. (1992) Drosophila Information Service 71, 150 |
| 25. |
Rubin, G. M.,
and Spradling, A. C.
(1982)
Science
218,
348-353 |
| 26. | Cartwright, I. L., Cryderman, D. E., Gilmour, D. S., Pile, L. A., Wallrath, L. L., Weber, J. A., and Elgin, S. C. R. (1999) Methods Enzymol. 304, 462-496[Medline] [Order article via Infotrieve] |
| 27. |
Cutler, G.,
Perry, K. M.,
and Tjian, R.
(1998)
Mol. Cell. Biol.
18,
2252-2261 |
| 28. | Glaser, R. L., Thomas, G. H., Siegfried, E., Elgin, S. C. R., and Lis, J. T. (1990) J. Mol. Biol. 211, 751-761[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Lee, H.-S.,
Kraus, K. W.,
Wolfner, M. F.,
and Lis, J. T.
(1992)
Genes Dev.
6,
284-295 |
| 30. |
Laney, J. D.,
and Biggin, M. D.
(1992)
Genes Dev.
6,
1531-1541 |
| 31. |
Gilmour, D. S.,
Thomas, G. H.,
and Elgin, S. C. R.
(1989)
Science
245,
1487-1490 |
| 32. |
Wilkins, R. C.,
and Lis, J. T.
(1998)
Nucleic Acids Res.
26,
2672-2678 |
| 33. |
Gao, J.,
and Benyajati, C.
(1998)
Nucleic Acids Res.
26,
5394-5401 |
| 34. | Geyer, P. K. (1997) Curr. Opin. Genet. Dev. 7, 242-248[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Soeller, W. C.,
Oh, C. E.,
and Kornberg, T. B.
(1993)
Mol. Cell. Biol.
13,
7961-7970 |
| 36. |
Benyajati, C.,
Mueller, L.,
Xu, N.,
Pappano, M.,
Gao, J .,
Mosammaparast, M.,
Conklin, D.,
Granok, H.,
Craig, C.,
and Elgin, S. C. R.
(1997)
Nucleic Acids Res.
25,
3345-3353 |
| 37. |
England, B. P.,
Admon, A.,
and Tjian, R.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
683-687 |
| 38. |
Elgin, S. C. R.
(1988)
J. Biol. Chem.
263,
19259-19262 |
| 39. |
Cartwright, I. L.,
and Elgin, S. C. R.
(1986)
Mol. Cell. Biol.
6,
779-791 |
| 40. |
Jenuwein, T.,
Forrester, W. C.,
Qui, R.-G.,
and Grosschedl, R.
(1993)
Genes Dev.
7,
2016-2032 |
| 41. | McCall, K., and Bender, W. (1996) EMBO J. 15, 569-580[Medline] [Order article via Infotrieve] |
| 42. |
Sandaltzopoulos, R.,
Mitchelmore, C.,
Bonte, E.,
Wall, G.,
and Becker, P. B.
(1995)
Nucleic Acids Res.
23,
2479-2487 |
| 43. | Tsukiyama, T., and Wu, C. (1995) Cell 83, 1011-1020[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Tjian, R., and Maniatis, T. (1994) Cell 77, 5-8[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Wilkins, R. C., and Lis, J. T. (1999) J. Mol. Biol. 285, 515-525[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Agianian, B., Leonard, K., Bonte, E., Van der Zandt, H., Becker, P. B., and Tucker, P. A. (1999) J. Mol. Biol. 285, 527-544[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Mason, P. B., Jr.,
and Lis, J. T.
(1997)
J. Biol. Chem.
272,
33227-33233 |
| 48. | Li, B., Weber, J. A., Chen, Y., Grennleaf, A. L., and Gilmour, D. S. (1996) Mol. Cell. Biol. 16, 5433-5443[Abstract] |
| 49. |
Benjamin, L. R.,
and Gilmour, D. S.
(1998)
Nucleic Acids Res.
26,
1051-1055 |
| 50. |
Jackson, J. R.,
and Benyajati, C.
(1992)
Nucleic Acids Res.
20,
5413-5422 |
| 51. |
Lu, Q.,
Wallrath, L. L.,
Granok, H.,
and Elgin, S. C. R.
(1993)
Mol. Cell. Biol.
13,
2802-2814 |
| 52. | Vashee, S., Melcher, K., Ding, W. V., Johnston, S. A., and Kodakek, T. (1998) Curr. Biol. 8, 452-458[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | Raff, J. W., Kellum, R., and Alberts, B. (1994) EMBO J. 13, 5977-5983[Medline] [Order article via Infotrieve] |
| 54. |
Platero, J. S.,
Csink, A. K.,
Quintanilla, A.,
and Henikoff, S.
(1998)
J. Cell Biol.
140,
1297-1306 |
| 55. |
Pazin, M. J.,
Kamakaka, R. T.,
and Kadonaga, J. T.
(1994)
Science
266,
2007-2011 |
| 56. |
Pazin, M. J.,
Sheridan, P. L.,
Cannon, K.,
Cao, Z.,
Keck, J. G.,
Kadonaga, J. T.,
and Jones, K. A.
(1996)
Genes Dev.
10,
37-49 |
This article has been cited by other articles:
![]() |
A. Kosoy, S. Pagans, M. L. Espinas, F. Azorin, and J. Bernues GAGA Factor Down-regulates Its Own Promoter J. Biol. Chem., October 25, 2002; 277(44): 42280 - 42288. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Leibovitch, Q. Lu, L. R. Benjamin, Y. Liu, D. S. Gilmour, and S. C. R. Elgin GAGA Factor and the TFIID Complex Collaborate in Generating an Open Chromatin Structure at the Drosophila melanogaster hsp26 Promoter Mol. Cell. Biol., September 1, 2002; 22(17): 6148 - 6157. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Urnov and A. P. Wolffe A Necessary Good: Nuclear Hormone Receptors and Their Chromatin Templates Mol. Endocrinol., January 1, 2001; 15(1): 1 - 16. [Full Text] |
||||
![]() |
A. Vaquero, M. L. Espinas, F. Azorin, and J. Bernues Functional Mapping of the GAGA Factor Assigns Its Transcriptional Activity to the C-terminal Glutamine-rich Domain J. Biol. Chem., June 23, 2000; 275(26): 19461 - 19468. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||